Electrical Stimulation Of The Brain For Restoring Vision
Funder
National Health and Medical Research Council
Funding Amount
$1,555,864.00
Summary
This project is focused on the clinical demonstration of the Monash Vision Group’s ‘Gennaris’ cortical prosthesis or bionic eye. The clinical work will demonstrate the use of the Gennaris as a viable medical device that provides useful vision to people with adult-onset profound vision loss in their everyday living environments. This will place MVG in a position to attract funding from investors or commercial partners to perform multi-site clinical trials and obtain regulatory approval.
Plasma Lipid Profiling For Risk Assessment Of Unstable Coronary Artery Disease
Funder
National Health and Medical Research Council
Funding Amount
$512,316.00
Summary
Age, sex, smoking, blood pressure and cholesterol level are risk factors for the development of heart disease. Most adults belong to an intermediate-risk group in which the predictive power of current risk factors is low. Most heart attacks occur in this group. Consequently, many individuals at risk are not properly identified nor treated appropriately. We are developing a new test to accurately assess risk of a future heart attack that will address this deficiency in our health system.
PEERS: Developing An IPad-delivered Social Assessment Tool For Children And Adolescents
Funder
National Health and Medical Research Council
Funding Amount
$898,094.00
Summary
We will produce a tool to identify social impairments in children and adolescents. The tool, called PEERSTM (Paediatric Evaluation of Emotions, Relationships & Socialisation), is at the forefront of digital health, combining cutting edge research with technology for increased accuracy, speed and efficiencies within the healthcare system. It is: i) based on social neuroscience theory; ii) supported by poof-of-concept data; and iii) of high relevance to health professionals and educators.
From The Synchrotron To The Clinic: Translation Of A Novel Functional Lung Imaging Technology
Funder
National Health and Medical Research Council
Funding Amount
$891,834.00
Summary
Our team has recently developed a synchrotron technology with a startling capacity for dynamic functional imaging that can act as a sensitive regional indicator of lung disease. We will demonstrate that this technology can be translated from the synchrotron to the lab and eventually the clinic. We will provide proof of this concept by the application of this technology to emphysema, asthma, lung cancer, cystic fibrosis lung disease and neonatal resuscitation.